Prenatal diagnosis in severe cases: a new gain in Portuguese neonatal by Sousa, Carmen et al.
Prenatal diagnosis in severe cases: a new gain in Portuguese neonatal 
screening laboratory 
 
 
Carmen Sousa1, Célia Nogueira1, Helena Fonseca1, Ana Marcão1, Hugo Rocha1, Lurdes Lopes1, Elisa Leão2, Juliette 
Garcia3, Ana Bela Couceiro4 and Laura Vilarinho1 
  
1 Newborn Screening Unit Genetics Department – National Institute of Health Dr. Ricardo Jorge, Porto – Portugal 
2Hospital S.João, Porto, Portugal 
3Hospital Santa Maria, Lisboa, Portugal 
4Maternidade Bissaya Barreto,Coimbra, Portugal 
 
Introduction 
The Portuguese neonatal screening, based on 
MS/MS technology, allows since 2004 the 
tracing of 25 diseases, in a single laboratory in 
all Portuguese newborns. Following this 
expansion, the molecular study was also 
implemented for most diseases, thus allowing 
confirmation and prenatal diagnosis in severe 
cases. 
 
Methods 
Five prenatal diagnoses were made in 
pregnant women (first-trimester) who had 
children affected with severe forms of CPT2 
deficiency, ARG1 deficiency, MAD deficiency 
and LCHAD deficiency. Disease-causing 
mutations were previously identified in the 
index patients of families 1 and 2. Molecular 
genetic characterization of the probands of 
families 3-5 was given by the geneticists who 
requested prenatal.  
Genomic DNA was isolated from whole blood, 
cultured amniotic fluid cells or chorionic villous 
samples (CVS) by standard methods. 
Mutations were detected through direct 
sequencing of PCR products, performed on an 
automatic sequencer. 
In all samples maternal was excluded 
contamination (Molecular Unit-INSA). 
Results 
Three prenatal diagnoses were performed on 
mothers with affected children, found through 
neonatal screening: CPT2D, MADD and 
LCHADD. Two other prenatal diagnoses for 
ARG1D were requested from Italy (Family 4) and 
France Centers (Family 5). Results revealed two 
affected fetus (Family 1 and 2) and three 
heterozygous carriers (Family 3-5) (Table 1). The 
probands cases from families 1 and 3 deceased 
with 2 years and 2 days of life respectively. 
 
Table 1- DNA-based prenatal diagnosis in 5 families 
 
 
 
 
 
 
 
 
 
 
Discussion 
Molecular prenatal diagnosis for severe forms 
can establish the diagnosis in the first trimester 
of pregnancy. Nevertheless, this procedure is 
conditioned by prior knowledge of responsible 
mutations in the index cases. 
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                                       ETFDH  Genotype
Family Exon Proband Mother Father CVS
1 1 c.34+5G>C c.34+5G>C WT c.34+5G>C
12 c.1601C>T
1
WT c.1601C>T
1
c.1601C>T
1
                                       CPT2  Genotype
Family Exon Proband Mother Father CVS
2 1 c.110_111dupGC
2
WT c.110_111dupGC
2
c.110_111dupGC
2
1 c.110_111dupGC
2
c.110_111dupGC WT c.110_111dupGC
2
                                       HADHA  Genotype
Family Exon Proband Mother Father CVS
3 15 c.1528G>C
3
WT c.1528G>C
3
c.1528G>C
3
15 c.1528G>C
3
c.1528G>C
3
WT WT
                                       ARG1  Genotype
Family Exon Proband Mother Father CVS
4 1 c.23T>G WT c.23T>G c.23T>G
1 c.23T>G c.23T>G WT WT
Intron Amniocytes
5 4 c.466-2A>G
4
WT c.466-2A>G
4
c.466-2A>G
4
4 c.466-2A>G
4
c.466-2A>G
4
WT WT
